To assess the contribution of anti-apoptotic Bcl-2 proteins to BMM-mediated AML drug resistance, we tested if inhibition of Bcl-2/Bcl-XL can revert BMSC-mediated resistance to chemotherapeutics. This evidence concerns the gene BCL2 and acute myeloid leukemia.